Evidence map›Paper›PMID 41449350›Full record

ArticleBMC medical research methodology2025

Comparative effectiveness research with average hazard for censored time-to-event outcomes: simulation study and application to observational data.

Hong Xiong, Jean Connors, Deb Schrag, Hajime Uno

Abstract read
In one paragraph

Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hong XiongDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, 02115, USA.
Jean ConnorsDepartment of Hematologic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, 02215, USA.
Deb SchragDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, 10065, USA.
Hajime UnoDepartment of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts, 02215, USA. huno@ds.dfci.harvard.edu.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Survival Data Analysis using general censoring-free incident rateR01GM152499 · NIGMS · DANA-FARBER CANCER INST · PI Hajime Uno · 2024 to 2026
$1.0M
NCI NIH HHS P30 CA008748NIGMS NIH HHS R01 GM152499NIGMS NIH HHS R01GM152499Patient-Centered Outcomes Research Institute CE-1304-6543
6 · The paper itself

Abstract

backgroundThe average hazard is a summary measure of event time distributions with a given time window, [Formula: see text] and allows intuitive interpretation as an average person-time incidence rate over the time window. This metric is calculated as the ratio of the cumulative incidence probability at τ to the restricted mean survival time at τ and can be estimated through non-parametric methods and thus robust. While previously proposed for randomized trials, its use in comparative effectiveness research remains underexplored.

methodsWe evaluate inference procedures for the difference and ratio of average hazards from two comparative groups, using six common confounding adjustment methods for survival functions, including direct standardization, inverse probability of treatment weighting (IPTW), propensity score matching, empirical likelihood, and augmented IPTW (AIPTW). Extensive simulation studies under varying model specification are conducted to assess bias, variance, coverage probability, and width of confidence interval. We apply the method to data from the preference cohort in the CANVAS study.

resultsAll adjustment methods achieved satisfactory performance; AIPTW was notably robust under partial model misspecification.

conclusionsUsing difference in average hazards and ratio of average hazards as estimands, when combined with common confounding adjustment methods, is feasible and reliable for comparative effectiveness research. The average hazard-based analysis provides a practical alternative to the traditional hazard ratio approach for quantifying the magnitude of the intervention effect on survival outcomes.

Indexed as

Comparative Effectiveness ResearchOutcome Assessment, Health CareComputer SimulationHumansModels, StatisticalObservational Studies as TopicProbabilityPropensity ScoreProportional Hazards ModelsSurvival AnalysisAdjusted survival curvesCausal inferenceCumulative incidence probabilityPerson-time incidence rateRestricted mean survival time

Identifiers

PMID41449350
PMCPMC12849754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.